WO2002059609A3 - Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators - Google Patents

Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators Download PDF

Info

Publication number
WO2002059609A3
WO2002059609A3 PCT/US2001/048368 US0148368W WO02059609A3 WO 2002059609 A3 WO2002059609 A3 WO 2002059609A3 US 0148368 W US0148368 W US 0148368W WO 02059609 A3 WO02059609 A3 WO 02059609A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
cancer
colorectal cancer
breast cancer
breast
Prior art date
Application number
PCT/US2001/048368
Other languages
French (fr)
Other versions
WO2002059609A2 (en
Inventor
David H Mack
Kurt C Gish
Keith E Wilson
Original Assignee
Eos Biotechnology Inc
David H Mack
Kurt C Gish
Keith E Wilson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/733,756 external-priority patent/US20030198951A1/en
Priority claimed from US09/733,757 external-priority patent/US20020102544A1/en
Application filed by Eos Biotechnology Inc, David H Mack, Kurt C Gish, Keith E Wilson filed Critical Eos Biotechnology Inc
Priority to CA002431313A priority Critical patent/CA2431313A1/en
Priority to JP2002559675A priority patent/JP2005506514A/en
Priority to EP01994241A priority patent/EP1410035A2/en
Priority to MXPA03005004A priority patent/MXPA03005004A/en
Publication of WO2002059609A2 publication Critical patent/WO2002059609A2/en
Publication of WO2002059609A3 publication Critical patent/WO2002059609A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Described herein are methods that can be used for diagnosis and prognosis of breast and/or colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast and/or colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast and/or colorectal cancer are described.
PCT/US2001/048368 2000-12-08 2001-12-10 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators WO2002059609A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002431313A CA2431313A1 (en) 2000-12-08 2001-12-10 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
JP2002559675A JP2005506514A (en) 2000-12-08 2001-12-10 Colorectal cancer and / or breast cancer diagnostic method, colorectal cancer and / or breast cancer modulator composition and screening method
EP01994241A EP1410035A2 (en) 2000-12-08 2001-12-10 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
MXPA03005004A MXPA03005004A (en) 2000-12-08 2001-12-10 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/733,757 2000-12-08
US09/733,756 2000-12-08
US09/733,756 US20030198951A1 (en) 1999-12-02 2000-12-08 Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
US09/733,757 US20020102544A1 (en) 2000-09-15 2000-12-08 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators

Publications (2)

Publication Number Publication Date
WO2002059609A2 WO2002059609A2 (en) 2002-08-01
WO2002059609A3 true WO2002059609A3 (en) 2004-02-12

Family

ID=27112622

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/048368 WO2002059609A2 (en) 2000-12-08 2001-12-10 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators

Country Status (5)

Country Link
EP (1) EP1410035A2 (en)
JP (1) JP2005506514A (en)
CA (1) CA2431313A1 (en)
MX (1) MXPA03005004A (en)
WO (1) WO2002059609A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0713098A2 (en) * 2006-05-22 2012-10-16 Clinical Genomics Pty Ltd method for determining the anatomical origin of an individual's large intestine-derived cell or cell population, detection method for determining the anatomical origin of an individual's large intestine-derived cell or cell population, detection system, legible storage medium by computer, nucleic acid arrangement, use of an arrangement, method for determining the onset or predisposition for the onset of a cellular abnormality or a condition distinguished by a cellular abnormality in the large intestine, diagnostic kit for assaying biological samples
PL2338907T3 (en) * 2007-07-27 2016-03-31 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
BRPI0814140A2 (en) * 2007-07-27 2017-03-28 Immatics Biotechnologies Gmbh tumor-associated peptide composition and cancer-related vaccine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030673A1 (en) * 1998-11-20 2000-06-02 Genentech, Inc. Uses for eph receptor antagonists and agonists to treat vascular disorders
WO2001094629A2 (en) * 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030673A1 (en) * 1998-11-20 2000-06-02 Genentech, Inc. Uses for eph receptor antagonists and agonists to treat vascular disorders
WO2001094629A2 (en) * 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"ASCO Clinical Practice Guidelines on Tumour Markers in Breast and Colorectal Cancer", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 33, no. 1, January 1997 (1997-01-01), pages 2, XP004282374, ISSN: 0959-8049 *
DATABASE EMBL [online] XP002249319, accession no. EBI Database accession no. aw780303 *

Also Published As

Publication number Publication date
MXPA03005004A (en) 2004-09-10
WO2002059609A2 (en) 2002-08-01
CA2431313A1 (en) 2002-08-01
JP2005506514A (en) 2005-03-03
EP1410035A2 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
WO2001031335A3 (en) Cell proliferation diagnosis and screening for modulators
WO2002021996A3 (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
WO2000055629A3 (en) Methods of diagnosing and treating breast cancer
WO2000055633A3 (en) Methods of screening for colorectal cancer modulators
WO2002055988A3 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
WO2002059377A3 (en) Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
WO2003025138A3 (en) Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
WO2004070062A3 (en) Compositions and methods for diagnosing and treating cancers
WO2003042661A8 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
WO2002102235A3 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
WO2004063355A3 (en) Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
WO2001011086A3 (en) Methods of screening for angiogenesis modulators
WO2002014503A3 (en) Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies
WO2004048938A3 (en) Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
WO2001092581A8 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2002074156A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2002012328A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1570081A4 (en) Amplified genes involved in cancer
WO2002058534A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2002064839A3 (en) Methods for the diagnosis and treatment of tumors employing the hepsin gene
WO2002016939A3 (en) Methods of diagnosis of cancer and screening for cancer modulators
WO2002012280A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2002059609A3 (en) Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
WO2002039885A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2003013431A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/005004

Country of ref document: MX

Ref document number: 2431313

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002559675

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001994241

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001994241

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001994241

Country of ref document: EP